{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:08:32Z","timestamp":1793722112304,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Catheter ablation and antiarrhythmic drug therapy are utilized for rhythm control in atrial fibrillation (AF), but their comparative effectiveness, especially with contemporary treatment modalities, remains undefined. We conducted a systematic review and meta-analysis contrasting current ablation techniques against antiarrhythmic medications for AF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched PubMed, SCOPUS, Cochrane CENTRAL, and Web of Science until November 2023 for randomized trials comparing AF catheter ablation with antiarrhythmics, against antiarrhythmic drug therapy alone, reporting outcomes for &gt;\u20096 months. Four investigators extracted data and appraised risk of bias (ROB) with ROB 2 tool. Meta-analyses estimated pooled efficacy and safety outcomes using R software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twelve trials (<jats:italic>n<\/jats:italic>\u2009=\u20093977) met the inclusion criteria. Catheter ablation was associated with lower AF recurrence (relative risk (RR)\u2009=\u20090.44, 95%CI (0.33, 0.59), <jats:italic>P<\/jats:italic> \u02c2 0.0001) and hospitalizations (RR\u2009=\u20090.44, 95%CI (0.23, 0.82), <jats:italic>P<\/jats:italic>\u2009=\u20090.009) than antiarrhythmic medications. Catheter ablation also improved the physical quality of life component score (assessed by a 36-item Short Form survey) by 7.61 points (95%CI -0.70-15.92, <jats:italic>P<\/jats:italic>\u2009=\u20090.07); but, due to high heterogeneity, it was not statistically significant. Ablation was significantly associated with higher procedural-related complications [RR\u2009=\u200915.70, 95%CI (4.53, 54.38), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001] and cardiac tamponade [RR\u2009=\u20099.22, 95%CI (2.16, 39.40), <jats:italic>P<\/jats:italic>\u2009=\u20090.0027]. All-cause mortality was similar between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For symptomatic AF, upfront catheter ablation reduces arrhythmia and hospitalizations better than continued medical therapy alone, albeit with moderately more adverse events. Careful patient selection and risk-benefit assessment are warranted regarding the timing of ablation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03983-z","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:03:07Z","timestamp":1719309787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Subhash","family":"Chander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Luhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Shiwlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Sorath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqub Nadeem","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhi Chand","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Sakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Vaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Sadarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"2","key":"3983_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217\u201321. https:\/\/doi.org\/10.1177\/1747493019897870. (In eng).","journal-title":"Int J Stroke"},{"issue":"1","key":"3983_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4022\/jafib.467","volume":"5","author":"S Bordignon","year":"2012","unstructured":"Bordignon S, Chiara Corti M, Bilato C. Atrial fibrillation associated with heart failure, stroke and mortality. J Atr Fibrillation. 2012;5(1):467. https:\/\/doi.org\/10.4022\/jafib.467. (In eng).","journal-title":"J Atr Fibrillation"},{"issue":"1","key":"3983_CR3","first-page":"109","volume":"3","author":"P Kakar","year":"2007","unstructured":"Kakar P, Boos CJ, Lip GY. Management of atrial fibrillation. Vasc Health Risk Manag. 2007;3(1):109\u201316. (In eng).","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"3983_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/agm2.12015","volume":"1","author":"Q Chen","year":"2018","unstructured":"Chen Q, Yi Z, Cheng J. Atrial fibrillation in aging population. Aging Med (Milton). 2018;1(1):67\u201374. https:\/\/doi.org\/10.1002\/agm2.12015. (In eng).","journal-title":"Aging Med (Milton)"},{"issue":"23","key":"3983_CR5","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/circulationaha.111.069450","volume":"125","author":"M Rienstra","year":"2012","unstructured":"Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012;125(23):2933\u201343. https:\/\/doi.org\/10.1161\/circulationaha.111.069450. (In eng).","journal-title":"Circulation"},{"issue":"12","key":"3983_CR6","doi-asserted-by":"publisher","first-page":"e007809","DOI":"10.1161\/circep.119.007809","volume":"12","author":"D Qin","year":"2019","unstructured":"Qin D, Mansour MC, Ruskin JN, Heist EK. Atrial fibrillation-mediated cardiomyopathy. Circ Arrhythm Electrophysiol. 2019;12(12):e007809. https:\/\/doi.org\/10.1161\/circep.119.007809. (In eng).","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"3983_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/circulationaha.111.019927","volume":"125","author":"P Zimetbaum","year":"2012","unstructured":"Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012;125(2):381\u20139. https:\/\/doi.org\/10.1161\/circulationaha.111.019927. (In eng).","journal-title":"Circulation"},{"issue":"11\u201312","key":"3983_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00424-016-1883-9","volume":"468","author":"JE Kirchhoff","year":"2016","unstructured":"Kirchhoff JE, Diness JG, Abildgaard L, Sheykhzade M, Grunnet M, Jespersen T. Antiarrhythmic effect of the ca(2+)-activated K(+) (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation. Pflugers Arch. 2016;468(11\u201312):1853\u201363. https:\/\/doi.org\/10.1007\/s00424-016-1883-9. (In eng).","journal-title":"Pflugers Arch"},{"issue":"Suppl 1","key":"3983_CR9","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.amjcard.2023.08.029","volume":"205","author":"TF Deering","year":"2023","unstructured":"Deering TF, Reiffel JA, Solomon AJ, Tamirisa KP. Chapter 5: Guideline recommendations: which AAD and for whom? Am J Cardiol. 2023;205(Suppl 1):S16\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.029. (In eng).","journal-title":"Am J Cardiol"},{"issue":"3","key":"3983_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7861\/clinmedicine.16-3-267","volume":"16","author":"R Ang","year":"2016","unstructured":"Ang R, Earley MJ. The role of catheter ablation in the management of atrial fibrillation. Clin Med (Lond). 2016;16(3):267\u201371. https:\/\/doi.org\/10.7861\/clinmedicine.16-3-267. (In eng).","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"3983_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.15420\/aer.2018.7.3","volume":"7","author":"F Ke\u00e7e","year":"2018","unstructured":"Ke\u00e7e F, Zeppenfeld K, Trines SA. The impact of advances in atrial fibrillation ablation devices on the incidence and prevention of complications. Arrhythm Electrophysiol Rev. 2018;7(3):169\u201380. https:\/\/doi.org\/10.15420\/aer.2018.7.3. (In eng).","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"3983_CR12","doi-asserted-by":"publisher","first-page":"101292","DOI":"10.1016\/j.ijcha.2023.101292","volume":"49","author":"A Parlavecchio","year":"2023","unstructured":"Parlavecchio A, Vetta G, Coluccia G, et al. Catheter ablation in patients with paroxysmal atrial fibrillation and absence of structural heart disease: a meta-analysis of randomized trials. Int J Cardiol Heart Vasc. 2023;49:101292. https:\/\/doi.org\/10.1016\/j.ijcha.2023.101292. (In eng).","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"2","key":"3983_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3892\/etm.2015.2545","volume":"10","author":"LZ Shi","year":"2015","unstructured":"Shi LZ, Heng R, Liu SM, Leng FY. Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: a meta-analysis of randomized controlled trials. Exp Ther Med. 2015;10(2):816\u201322. https:\/\/doi.org\/10.3892\/etm.2015.2545. (In eng).","journal-title":"Exp Ther Med"},{"issue":"1","key":"3983_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12916-022-02385-2","volume":"20","author":"E Charitakis","year":"2022","unstructured":"Charitakis E, Metelli S, Karlsson LO, et al. Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: a network meta-analysis. BMC Med. 2022;20(1):193. https:\/\/doi.org\/10.1186\/s12916-022-02385-2.","journal-title":"BMC Med"},{"key":"3983_CR15","doi-asserted-by":"publisher","unstructured":"McBride S, Avazzadeh S, Wheatley AM, et al. Ablation modalities for therapeutic intervention in Arrhythmia-related Cardiovascular Disease: Focus on Electroporation. J Clin Med. 2021;10(12). https:\/\/doi.org\/10.3390\/jcm10122657. (In eng).","DOI":"10.3390\/jcm10122657"},{"issue":"10","key":"3983_CR16","doi-asserted-by":"publisher","first-page":"Ed000142","DOI":"10.1002\/14651858.Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142. https:\/\/doi.org\/10.1002\/14651858.Ed000142. (In eng).","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3983_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006. (In eng).","journal-title":"J Clin Epidemiol"},{"key":"3983_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"17","key":"3983_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"LD Biase","year":"2016","unstructured":"Biase LD, Mohanty P, Mohanty S, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device. Circulation. 2016;133(17):1637\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019406.","journal-title":"Circulation"},{"issue":"7","key":"3983_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jama.2014.467","volume":"311","author":"CA Morillo","year":"2014","unstructured":"Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692\u2013700. https:\/\/doi.org\/10.1001\/jama.2014.467. (In eng).","journal-title":"JAMA"},{"issue":"8","key":"3983_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","volume":"35","author":"L Mont","year":"2014","unstructured":"Mont L, Bisbal F, Hern\u00e1ndez-Madrid A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/eht457. (In eng).","journal-title":"Eur Heart J"},{"issue":"13","key":"3983_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261\u201374. https:\/\/doi.org\/10.1001\/jama.2019.0693. (In eng).","journal-title":"JAMA"},{"issue":"1","key":"3983_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","volume":"20","author":"GB Forleo","year":"2009","unstructured":"Forleo GB, Mantica M, De Luca L, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20(1):22\u20138. https:\/\/doi.org\/10.1111\/j.1540-8167.2008.01275.x. (In eng).","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"3983_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333\u201340. https:\/\/doi.org\/10.1001\/jama.2009.2029. (In eng).","journal-title":"JAMA"},{"issue":"3","key":"3983_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","volume":"23","author":"KH Kuck","year":"2021","unstructured":"Kuck KH, Lebedev DS, Mikhaylov EN, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23(3):362\u20139. https:\/\/doi.org\/10.1093\/europace\/euaa298. (In eng).","journal-title":"Europace"},{"issue":"24","key":"3983_CR26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1161\/circulationaha.108.772582","volume":"118","author":"P Ja\u00efs","year":"2008","unstructured":"Ja\u00efs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498\u2013505. https:\/\/doi.org\/10.1161\/circulationaha.108.772582. (In eng).","journal-title":"Circulation"},{"issue":"11","key":"3983_CR27","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","volume":"48","author":"C Pappone","year":"2006","unstructured":"Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2006.08.037. (In eng).","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"3983_CR28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","volume":"367","author":"J Cosedis Nielsen","year":"2012","unstructured":"Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1113566. (In eng).","journal-title":"N Engl J Med"},{"issue":"21","key":"3983_CR29","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","volume":"293","author":"OM Wazni","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634\u201340. https:\/\/doi.org\/10.1001\/jama.293.21.2634. (In eng).","journal-title":"JAMA"},{"issue":"9","key":"3983_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJMoa050955","volume":"354","author":"H Oral","year":"2006","unstructured":"Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934\u201341. https:\/\/doi.org\/10.1056\/NEJMoa050955. (In eng).","journal-title":"N Engl J Med"},{"issue":"6","key":"3983_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","volume":"6","author":"MK Turagam","year":"2021","unstructured":"Turagam MK, Musikantow D, Whang W, et al. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials. JAMA Cardiol. 2021;6(6):697\u2013705. https:\/\/doi.org\/10.1001\/jamacardio.2021.0852. (In eng).","journal-title":"JAMA Cardiol"},{"issue":"10","key":"3983_CR32","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.21037\/apm-21-2313","volume":"10","author":"P Wang","year":"2021","unstructured":"Wang P, He W, Li C, Xiang T, Yang Q, Chen Q. A systematic review and meta-analysis of catheter ablation for atrial fibrillation. Ann Palliat Med. 2021;10(10):10542\u201355. https:\/\/doi.org\/10.21037\/apm-21-2313. (In eng).","journal-title":"Ann Palliat Med"},{"issue":"9","key":"3983_CR33","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1097\/ms9.0000000000000985","volume":"85","author":"MM Zahoor","year":"2023","unstructured":"Zahoor MM, Ullah SE, Kidiavai HM, et al. Efficacy of ablation therapy on clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. Ann Med Surg (Lond). 2023;85(9):4491\u2013500. https:\/\/doi.org\/10.1097\/ms9.0000000000000985. (In eng).","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"3983_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jjcc.2022.02.005","volume":"80","author":"T Yamane","year":"2022","unstructured":"Yamane T. Catheter ablation of atrial fibrillation: current status and near future. J Cardiol. 2022;80(1):22\u20137. https:\/\/doi.org\/10.1016\/j.jjcc.2022.02.005. (In eng).","journal-title":"J Cardiol"},{"issue":"42","key":"3983_CR35","doi-asserted-by":"publisher","first-page":"e35518","DOI":"10.1097\/md.0000000000035518","volume":"102","author":"X Wang","year":"2023","unstructured":"Wang X, Li M, Wang X, Zhang Z. It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: a systematic review and meta-analysis of cohort studies. Med (Baltim). 2023;102(42):e35518. https:\/\/doi.org\/10.1097\/md.0000000000035518. (In eng).","journal-title":"Med (Baltim)"},{"issue":"3","key":"3983_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2014.3.3.177","volume":"3","author":"AY Chang","year":"2014","unstructured":"Chang AY, Kaiser D, Ullal A, Perino AC, Heidenreich PA, Turakhia MP. Evaluating the cost-effectiveness of catheter ablation of atrial fibrillation. Arrhythm Electrophysiol Rev. 2014;3(3):177\u201383. https:\/\/doi.org\/10.15420\/aer.2014.3.3.177. (In eng).","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"6","key":"3983_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jval.2021.10.014","volume":"25","author":"M Hu","year":"2022","unstructured":"Hu M, Han Y, Zhao W, Chen W. Long-term cost-effectiveness comparison of catheter ablation and antiarrhythmic drugs in atrial fibrillation treatment using discrete event simulation. Value Health. 2022;25(6):975\u201383. https:\/\/doi.org\/10.1016\/j.jval.2021.10.014. (In eng).","journal-title":"Value Health"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03983-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:03:58Z","timestamp":1719309838000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03983-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3983"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03983-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this study utilized publicly available literature, approval from the institutional review board was not obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}